Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone in Large Ischemic Stroke
NCT07603440Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2026
- Primary completion
- Jul 2029
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07603440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07603440.